Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine MRI and Cognition in Moderate Alzheimer's
NCT00334906Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Jul 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Forest Laboratories. Started Jul 2005; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00334906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334906.